These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 6327962)
61. [Dynamics of secretion of hypothalamo-hypophyseal system hormones in Itsenko-Cushing disease as affected by combination therapy]. Slavnov VN; Valueva GV; Luchitskiĭ EV; Komissarenko IV; Cheban AK Probl Endokrinol (Mosk); 1983; 29(6):28-32. PubMed ID: 6140677 [TBL] [Abstract][Full Text] [Related]
62. Six year remission of ACTH-dependent Cushing's syndrome using bromocriptine. Atkinson AB; Kennedy AL; Sheridan B Postgrad Med J; 1985 Mar; 61(713):239-42. PubMed ID: 2984649 [TBL] [Abstract][Full Text] [Related]
63. [Prolonged remission in Cushing's syndrome following treatment with ortho-para-dichlordiphenyldichlorethane]. Kirkegaard C; Kolendorf K Ugeskr Laeger; 1974 Jun; 136(25):1389-91. PubMed ID: 4366485 [No Abstract] [Full Text] [Related]
64. A cyproheptadine-reversible defect in ACTH control persisting after removal of the pituitary tumor in Cushing's disease. Lankford HV; Tucker HS; Blackard WG N Engl J Med; 1981 Nov; 305(21):1244-8. PubMed ID: 6270557 [TBL] [Abstract][Full Text] [Related]
65. [Medical treatment and Cushing's disease]. Luton JP; Ghnassia JP; Bricaire H Sem Hop; 1977 Jun; 53(24):1476-9. PubMed ID: 197640 [TBL] [Abstract][Full Text] [Related]
72. Ketoconazole treatment for Cushing syndrome in McCune-Albright syndrome. Vong CH; Forest M; Nicolino M J Pediatr; 2009 Mar; 154(3):467-8; author reply 468-9. PubMed ID: 19874777 [No Abstract] [Full Text] [Related]
73. [Clinical remission in Cushing's disease through treatment with sodium valproate and bromocriptine]. García Rojas JF; Mangas Rojas A; Barba Chacón A; García Osle M; Zamora Madaria E Rev Clin Esp; 1991 Jan; 188(1):37-40. PubMed ID: 2063025 [TBL] [Abstract][Full Text] [Related]
74. [Recovery or remission of Cushing's disease following long term administration of OP'DDD in seventeen patients (author's transl)]. Luton JP; Remy JM; Valcke JC; Laudat P; Bricaire H Ann Endocrinol (Paris); 1973; 34(4):351-76. PubMed ID: 4360563 [No Abstract] [Full Text] [Related]
75. Cyproheptadine inhibits the corticotropin releasing hormone (CRH)--induced hormone release in normal subjects. Allolio B; Schulte HM; Deuss U; Winkelmann W Horm Metab Res Suppl; 1987; 16():36-8. PubMed ID: 2832287 [TBL] [Abstract][Full Text] [Related]
76. The biochemical investigation of Cushing syndrome. Simard M Neurosurg Focus; 2004 Apr; 16(4):E4. PubMed ID: 15191333 [TBL] [Abstract][Full Text] [Related]
79. Effects of cyproheptadine, reserpine, and synthetic corticotropin-releasing factor on pituitary glands from patients with Cushing's disease. Suda T; Tozawa F; Mouri T; Sasaki A; Shibasaki T; Demura H; Shizume K J Clin Endocrinol Metab; 1983 Jun; 56(6):1094-9. PubMed ID: 6302123 [TBL] [Abstract][Full Text] [Related]
80. [Clinical and biological study of an inhibitor of adrenocortical hormone synthesis: aminoglutethinide]. Philbert M; Laudat MH; Laudat P; Bricaire H Ann Endocrinol (Paris); 1968; 29(2):189-210. PubMed ID: 4298418 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]